Delivery Order SPE2DB22D3501-SPE2DB25FXL63
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $7.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a $2,262.01 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Feraheme 510 mg/17 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price contract, valued at $17,427.93, is a non-set-aside award representing a competitively awarded delivery order with an ultimate completion date of September 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.44 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 10, 2025, with completion expected by September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price delivery order, valued at $6,486.54, represents a non-competitive set-aside contract with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Feraheme is an intravenous iron replacement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Feraheme 510 mg/17 ml vials, with a ceiling value of $4,478.39. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,598.26 to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 mL vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Feraheme is an iron replacement therapeutic used in medical treatment, and this delivery order fulfills a specific...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Feraheme 510 mg/17 ml vials with a ceiling value of $14,513.96. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a small-value pharmaceutical procurement supporting federal medical needs. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- This is a $11,747.07 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a specialty pharmaceutical product used in the treatment of iron deficiency anemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA,...